Suppr超能文献

一级亲属中炎症性肠病与结直肠癌风险的关联:瑞典全国范围内的病例对照研究。

Association of inflammatory bowel disease in first-degree relatives with risk of colorectal cancer: A nationwide case-control study in Sweden.

机构信息

Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, Massachusetts, USA.

Department of Clinical Science and Education Södersjukhuset, Karolinska Institute, Stockholm, Sweden.

出版信息

Int J Cancer. 2023 Jun 1;152(11):2303-2313. doi: 10.1002/ijc.34470. Epub 2023 Feb 20.

Abstract

This study aims to assess the association between inflammatory bowel disease (IBD) history in first-degree relatives (FDRs) and colorectal cancer (CRC) risk. We conducted a nationwide case-control study in Sweden among 69 659 CRC cases and 343 032 non-CRC controls matched on age, sex, birth year and residence county. Through linkage of multi-generation register and the nationwide ESPRESSO (Epidemiology Strengthened by histoPathology Reports in Sweden) cohort, we ascertained IBD diagnoses among parents, full siblings and offspring of the index individuals. Odds ratios (ORs) of CRC associated with IBD family history were calculated using conditional logistic regression. 2.2% of both CRC cases (1566/69659) and controls (7676/343027) had ≥1 FDR with IBD history. After adjusting for family history of CRC, we observed no increased risk of CRC in FDRs of IBD patients (OR, 0.96; 95%CI, 0.91-1.02). The null association was consistent according to IBD subtype (Crohn's disease or ulcerative colitis), number of FDRs with IBD (1 or ≥ 2), age at first IBD diagnosis in FDRs (<18, 18-39, 40-59 or ≥60 years), maximum location/extent of IBD or FDR relation (parent, sibling or offspring). The null association remained for early-onset CRC (diagnosed at age <50 years). In conclusion, IBD history in FDRs was not associated with an increased risk of CRC. Our findings suggest that extra screening for CRC may not be needed in the offspring, siblings or parents of IBD patients, and strengthen the theory that it is the actual inflammation or atypia of the colon in IBD patients that confers the increased CRC risk.

摘要

这项研究旨在评估一级亲属(FDRs)中炎症性肠病(IBD)病史与结直肠癌(CRC)风险之间的关联。我们在瑞典进行了一项全国范围内的病例对照研究,纳入了 69659 例 CRC 病例和 343032 名非 CRC 对照,匹配年龄、性别、出生年份和居住县。通过多代登记处和全国范围内的 ESPRESSO(瑞典组织病理学报告强化流行病学)队列的链接,我们确定了指数个体的父母、全兄弟姐妹和子女的 IBD 诊断。使用条件逻辑回归计算与 IBD 家族史相关的 CRC 的比值比(OR)。CRC 病例(1566/69659)和对照(7676/343027)中分别有 2.2%和 2.2%有至少 1 个 FDR 有 IBD 病史。在调整了 CRC 家族史后,我们没有观察到 IBD 患者的 FDR 患 CRC 的风险增加(OR,0.96;95%CI,0.91-1.02)。这种无关联的结果与 IBD 亚型(克罗恩病或溃疡性结肠炎)、FDR 中有 IBD 病史的数量(1 个或≥2 个)、FDR 中 IBD 的首次诊断年龄(<18 岁、18-39 岁、40-59 岁或≥60 岁)、IBD 的最大位置/范围或 FDR 关系(父母、兄弟姐妹或子女)无关。对于早发性 CRC(<50 岁诊断),这种无关联的结果仍然存在。总之,FDR 中的 IBD 病史与 CRC 风险增加无关。我们的研究结果表明,IBD 患者的子女、兄弟姐妹或父母可能不需要额外进行 CRC 筛查,并进一步支持这样一种理论,即 IBD 患者的结肠实际炎症或非典型性导致了 CRC 风险的增加。

相似文献

4
Antibiotic use and the development of inflammatory bowel disease: a national case-control study in Sweden.
Lancet Gastroenterol Hepatol. 2020 Nov;5(11):986-995. doi: 10.1016/S2468-1253(20)30267-3. Epub 2020 Aug 17.
5
Age determines the risk of familial inflammatory bowel disease-A nationwide study.
Aliment Pharmacol Ther. 2022 Aug;56(3):491-500. doi: 10.1111/apt.16938. Epub 2022 Apr 22.
7
Colorectal cancer in elderly-onset inflammatory bowel disease: a 1969-2017 Scandinavian register-based cohort study.
Aliment Pharmacol Ther. 2022 Oct;56(7):1168-1182. doi: 10.1111/apt.17175. Epub 2022 Aug 2.
10
Familial Risk of Inflammatory Bowel Disease: A Population-Based Cohort Study in South Korea.
Clin Gastroenterol Hepatol. 2021 Oct;19(10):2128-2137.e15. doi: 10.1016/j.cgh.2020.09.054. Epub 2020 Oct 1.

引用本文的文献

1
Signaling pathways involved in colorectal cancer: pathogenesis and targeted therapy.
Signal Transduct Target Ther. 2024 Oct 7;9(1):266. doi: 10.1038/s41392-024-01953-7.
2
Greasing the Wheels of Pharmacotherapy for Colorectal Cancer: the Role of Natural Polyphenols.
Curr Nutr Rep. 2023 Dec;12(4):662-678. doi: 10.1007/s13668-023-00512-w. Epub 2023 Dec 2.

本文引用的文献

2
Age determines the risk of familial inflammatory bowel disease-A nationwide study.
Aliment Pharmacol Ther. 2022 Aug;56(3):491-500. doi: 10.1111/apt.16938. Epub 2022 Apr 22.
3
Twenty-first Century Trends in the Global Epidemiology of Pediatric-Onset Inflammatory Bowel Disease: Systematic Review.
Gastroenterology. 2022 Apr;162(4):1147-1159.e4. doi: 10.1053/j.gastro.2021.12.282. Epub 2022 Jan 5.
4
Colorectal Cancer in Inflammatory Bowel Disease: Mechanisms and Management.
Gastroenterology. 2022 Mar;162(3):715-730.e3. doi: 10.1053/j.gastro.2021.10.035. Epub 2021 Oct 29.
5
Screening for Colorectal Cancer: US Preventive Services Task Force Recommendation Statement.
JAMA. 2021 May 18;325(19):1965-1977. doi: 10.1001/jama.2021.6238.
6
Genetic and Epigenetic Characteristics of Inflammatory Bowel Disease-Associated Colorectal Cancer.
Gastroenterology. 2021 Aug;161(2):592-607. doi: 10.1053/j.gastro.2021.04.042. Epub 2021 Apr 27.
7
Rising incidence of early-onset colorectal cancer - a call to action.
Nat Rev Clin Oncol. 2021 Apr;18(4):230-243. doi: 10.1038/s41571-020-00445-1. Epub 2020 Nov 20.
8
Antibiotic use and the development of inflammatory bowel disease: a national case-control study in Sweden.
Lancet Gastroenterol Hepatol. 2020 Nov;5(11):986-995. doi: 10.1016/S2468-1253(20)30267-3. Epub 2020 Aug 17.
9
Colorectal cancer in Crohn's disease: a Scandinavian population-based cohort study.
Lancet Gastroenterol Hepatol. 2020 May;5(5):475-484. doi: 10.1016/S2468-1253(20)30005-4. Epub 2020 Feb 14.
10
Colorectal cancer in ulcerative colitis: a Scandinavian population-based cohort study.
Lancet. 2020 Jan 11;395(10218):123-131. doi: 10.1016/S0140-6736(19)32545-0.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验